OTraces
Chief Medical Officer 2008-2009
Company developed oligo-analyte screen including host response and
cancer biomarkers with AUC >.95 for cancers including breast and
prostate cancer.
- Refined regulatory strategy.
- Revised clinical trial strategy
TRAINING & LICENSING
- Northwestern University Medical School - Honors Program in
Medical Education B.A.;M.D.
- University of Colorado - Pathology Internship and Residency
- George Washington University - Pathology Fellowship
- Diplomat of the American Board of Pathology
- Licensed in California
1978-1981: Research Associate, National Cancer
Institute, Laboratory of Biochemistry (Chiefs: Robert Goldberger,
M.D., and Maxine Singer, Ph.D.), Biochemistry of Gene Expression
Section (Head: E. Brad Thompson). Studies on the control of
glucocorticoid inducible genes. The methods used included recombinant
DNA technology, somatic cell hybridizations, enzyme purification,
antibody production, and solution and filter hybridization of nucleic
acids. This work included differential screening of a rat liver cDNA
library to directly identify clones containing glucocorticoid-induced
or -repressed RNA sequences.
Developed a unique system using computerized image processing,
enhancement, and quantification to evaluate gene expression (Genomics)
via solution-solid phase hybridization to each member of a cDNA
library. This technology allowed detailed study of gene regulation and
isolation of specific recombinant clones. This new system is the
nucleic acid counterpart of comparative two-dimensional protein gel
electrophoresis.
1976-1978: Autopsy Supervisor, University of Colorado
Medical Center. Designed the program and was responsible for
supervising the autopsy-related work of up to 12 physicians. Favorable
evaluation led to the program's continuation after his tenure at UCMC
ended.
Research with Paul Nakane, Ph.D., Pathology
Department, University of Colorado Medical Center. Differentiation of
pituitary cells following endocrine manipulation in vivo was studied.
Techniques used included multiple peroxidase-labeled anti-hormone
antibodies and flow microfluorometry.
1974-1976: Research with Terry Johnson, Ph.D.,
Department of Microbiology, Northwestern University Medical School.
(Dr. Johnson is now Professor/Director of the Division of Biology,
Kansas State University.) A model system for pediatric brain damage in
the genetic disease phenylketonuria (PKU) was examined. Nucleic acid
and protein biochemistry defined the molecular site of inhibition of
protein synthesis in immature rat brain following phenylalanine
overloading. Based on this work, a new therapeutic approach was
devised. This approach was effective in an animal model of PKU.
1971: National Science Foundation Research
Participation Program Grantee for work with Aryeh Routtenberg, Ph.D.,
at Northwestern University Psychology Department. A novel method for
determination and documentation of functional relationships between
structurally diverse CNS regions was devised.
1968-1969: Research and study under Rulon Rawson,
M.D., Vice President and Dean, New Jersey College of Medicine and
Dentistry. In vivo studies of induction of red blood cell production
by erythropoietin (epo) following radiation injury were performed.
This work led to a Special Army Science Award. Epo class drugs have a
market of over $5 billion and for many years been the best selling
biotechnology drugs. The are used to treat fatigue. However unlike the
drugs Dr. Taub has recently developed their use is limited to those
with anemia.
Representative Invited Presentations:
- Cambridge Healthtech Institute, Baltimore, MD
- Cambridge Healthtech Institute, Tyson's Corner, VA
- A-T Children's Project, Longwood Gardens, PA
- Northwestern University, Evanston, IL
- Biogen, Geneva, Switzerland
- University of Chicago
- University of California-Los Angeles
- George Washington University, Washington, DC
- Bethesda Research Laboratories, Bethesda, MD
- Diabetes Telethon
- Physicians Radio Network
- XI Congreso de Investigacion Cientifica, San Juan, Puerto
Rico
- Society for Industrial Microbiology annual meeting,
Baltimore, MD
- Dental Research Programs Advisory Committee, NIH, Bethesda,
MD
- Baxter Healthcare Corporation, Deerfield, IL
- Montana Society of Pathologists, Great Falls, MT
- University of Texas Medical Branch, Galveston, TX
- Congressional subcommittee hearing on Technology Transfer,
Washington, DC
- Portfolio Management for the Biotech Industry, San Diego, CA
Societies (not all current):
- Academy for the Advancement of Medicine
- American Academy of Anti-Aging Medicine
- American Association for the Advancement of Science
- American Association for Clinical Chemistry
- American Society of Hematology
- American Society for Microbiology, American Society of
Clinical Pathologists
- Foundation for Advanced Education in the Sciences
- International Academy of Pathology
- New York Academy of Sciences
- Sigma Xi
- Society for Biological Therapy
- Honored Member Strathmore's Who's Who 2000-2001 (Millennium
Edition)
- The Official ABMS Directory of Certified Medical Specialists.
Historic Review of Medical Training
1970-1976
|
Entered Northwestern University's Honor Program in Medical
Education directly from high school. 1974, B.S. 1976,
M.D.
|
1975
|
Commissioned Jr. Assistant Surgeon, United States Public
Health Service.
|
1976-1978
|
Anatomic pathology internship and residency, University of
Colorado Medical Center. Subspecialty: endocrine pathology.
Training included ultrastructural, immunohistochemical, surgical,
and autopsy pathology. Autopsy supervisor, January to June,
1978.
|
1980
|
Promoted to Full Surgeon, United States Public Health
Service.
|
1981-1982
|
Surgical Pathology Fellow, George Washington University.
|
1982
|
Diplomat of the American Board of Pathology.
|
Current licenses to practice medicine in Maryland and California.
More than 50 publications in scientific literature. Inventor or
co-inventor on seven biomedical patents/applications.
Publications
Publications
(Papers):
- Routenberg A, Taub FE. Hippocampus
and superior colliculus: congruent EEG activity demonstrated by a
simple measure. Behav. Biol., 1973; 8: 80.
- Taub F and Johnson TJ. The
mechanism of polyribosome disaggregation in brain tissue by
phenylalanine. Biochem. J., 1975; 151: 173-180.
- DeLeo JM, Taub F, Thompson B.
Computer analysis of autoradiographic images of recombinant DNA
colonies. Division of Computer Research and Technology Annual
Report, 1981; 2:42-43.
- Taub FE and Thompson EB. An
improved method for preparing large arrays of bacterial colonies
containing plasmids for hybridization: in situ purification
and stable binding of DNA on paper filters. Anal. Biochem.,
1982; 126: 222-230.
- Taub FE, DeLeo JM and Thompson EB.
Sequential comparative hybridiza�tions analyzed by computerized
image processing can identify and quantitate regulated RNAs.
DNA, 1983; 2: 309-327.
- DeLeo JM, Taub F, Thompson B. Computer
analysis of autoradiographic images of recombinant DNA colonies.
Division of Computer Research and Technology Annual Report, 1983;
2:44-45.
- Taub FE. Class II antigen expression in
autoimmune disease. Lancet, 1984; 84:561.
- Ginsberg-Fellner F, ME Witt, B Fedun, F
Taub, MJ Dobersen, RC McEvoy, LZ Cooper, AL Notkins, P
Rubinstein. Diabetes mellitus and autoimmunity in patients with
the congenital rubella syndrome. Review of Infectious Diseases,
1985; 7 (Suppl. 1):S170-S176.
- Ginsberg-Fellner F, ME Witt, S Yagihashi, MJ Dobersen, F
Taub, B Fedun, RC McEvoy, SH Roman, TF Davies, LZ Cooper, P
Rubinstein, AL Notkins. Congenital rubella syndrome as a model for
type I (insulin-dependent) diabetes mellitus: increased prevalence
of islet cell antibodies. Diabetologia, 1984; 27:87-89.
- Ginsberg-Fellner F, ME Witt, S Yagihashi, MJ Dobersen, F
Taub, B Fedun, RC McEvoy, SH Roman, TF Davies, LZ Cooper, P
Rubinstein, AL Notkins. Congenital rubella syndrome as a model for
type I (insulin-dependent) diabetes mellitus: increased prevalence
of islet cell antibodies. Diabetologia, 1984; 27:87-89.
- Sutherland DER, R Sibley, X-Z Xu, A Michael, S Srikanta, F
Taub, J Najarian, FC Goetz (intro. by JH Oppenheimer).
Twin-to-twin pancreas transplantation: reversal and reenactment of
the pathogenesis of type I diabetes. Transactions of the
Association of American Physicians, 1984; 97:80-87.
- Garzelli C; Taub FE; Scharff JE;
Prabhakar BS, Ginsberg-Fellner F; Notkins AL. Epstein-Barr
virus-transformed lymphocytes produce monoclonal autoantibodies
that react with antigens in multiple organs. J Virol 1984;
52: 722-5.
- Taub, FE, Satoh, J, Garzelli, C, Essani,
K and Notkins, AL. Human monoclonal autoantibodies reactive
with multiple organs. Human Hybridomas and Monoclonal
Antibodies (eds. E.G. Engleman, et al.) Plenum Publishing
Corporation, New York, 1985.
- Eskinazi DP, J Satoh, CJ Wheeler, ET Harrison Jr., FE
Taub. Detection of antibodies reacting with live rat insulinoma
cells in the serum of patients with insulin-dependent diabetes
mellitus (IDDM) by an 125I-protein A microassay. Immunology
Letters, 1985; 10:353-354.
- Garzelli C, FE Taub, MC Jenkins, DW
Drell, F Ginsberg-Fellner, AL Notkins. Human monoclonal
autoantibodies that react with both pancreatic islets and thyroid.
Journal of Clinical Investigation, 1986; 77:1627-1631.
- Taub FE. DNA diagnostic techniques in
microbiology. SIM News, 1986; 36:6-7.
- Hakim FT, AD Steinberg, P Smathers, KS Brown, F
Taub, JJ Oppenheim. Hereditary joint disorder in progressive
ankylosis (ank/ank) mice: III. Involvement of the immune system.
Doctoral dissertation, University of Maryland, 1986.
- Taub FE, SL Grillo, CM Bruns, N Moore, ME
Mosher. The use of DNA probes to diagnose viral infections.
Developments in Industrial Microbiology, 1988; 29 (Journal of
Industrial Microbiology, Suppl. No. 3):119-129.
- Taub F. In situ hybridization in
surgical pathology. Advances in Surgical Pathology lecture at
George Washington University, Washington, DC. May 7, 1988.
- McClintock JT, Thaker SR, Mosher M, Jones D, Forman M,
Charache P, Wright K, Keiser J, Taub FE.
Comparison of in situ hybridization and monoclonal antibodies for
early detection of cytomegalovirus in cell culture. J Clin
Microbiol, 1989; 27: 1554-9.
- Higgs TW, Moore NJ, Badawi DY and Taub FE.
Type-specific HPV detection in formalin-fixed, paraffin-embedded
tissue sections using non-radioactive DNA probes. Laboratory
Investigation, 1990; 63: 557-567.
- Schoone GJ, van Eys GJ, Ligthart GS, Taub
FE, Zaal J, Mebrahtu Y, Laywer P. Detection and
identification of Leishmania parasites by in situ hybridization
with total and recombinant DNA probes. Exp Parasitol, 1991;
73: 345-53.
- McClintock JT, Mosher M, Thaker SR, Wacker WK, Jones D,
Forman M, Adler SP, Charache P, Taub FE.
Culture confirmation of cytomegalovirus and herpes simplex virus
by direct enzyme-labeled DNA probes and in situ
hybridization. J Virol Methods, 1991; 35: 81-91.
- McCarthy M, Resnick L, Taub F, Stewart
RV, Dix RD. Infection of human neural cell aggregate
cultures with a clinical isolate of cytomegalovirus. J
Neuropathol Exp Neurol, 1991; 50: 441-50.
- McClintock JT, Chan IJ, Thaker SR, Katial A, Taub
FE, Aotaki-Keen AE, Hjelmeland LM. Detection of c-sis
proto-oncogene transcripts by direct enzyme-labeled cDNA probes
and in situ hybridization. In Vitro Cell Dev Biol., 1992;
28: 102-8.
- McClintock JT, I-J Chan, SR Thaker, A Katial, FE
Taub, AE Aotaki-Keen, LM Hjelmeland. The detection of RNA
transcripts by non-radioactive in situ hybridization. In
preparation.
- McClintock JT; Chan IJ; Taub FE;
Friedman-Kien AE, Resnick L. Rapid detection of Epstein-Barr
virus DNA in clinical samples of oral hairy leukoplakia with
HRP-labeled DNA probes and in situ hybridization. J Virol
Methods, 33, 155-64 (1991.)
- Badawi DY, L Etienne, TW Higgs, NJ Moore, FE
Taub. Comparison study of non-radioactive probes for the rapid
detection of HPV in histological sections. In preparation.
- Lazar JG, Taub FE, Kessler C. A highly
sensitive method for detecting peroxidase in situ
hybridization or immunohistochemical assays. Nonradioactive
Labeling and Detection of Biomolecules Berlin: Springer-Verlag;
1992: 135-142.
- Dunn T, Wormsley S, Taub FE, and Pontzer
CH. Increased T cell cytotoxicity by Beta LTTM-induced
upregulation of TNF-alpha. International Journal of
Immunopharmacology. 2000: 22, 213-227.
Publications
(Abstracts):
- Sutherland DER, R Sibley, P Chinn, A Michael, S Srikanta,
F Taub, J Najarian, FC Goetz (intr. by JH
Oppenheimer). Twin-to-twin pancreas transplantation (TX): reversal
and reenactment of the pathogenesis of type I diabetes. Clinical
Research, 1984; 32:561A.
- Taub FE, J Scharff. Assay of islet cell
antibodies (ICA), a more sensitive method. Diabetes, 1984; 33
(Suppl. 1):63A.
- Yoon JW, JS Scharff, CJ Bachurski, TH Lee, FE
Taub. Antibody to islet cell antigens from
patients with Vacor induced insulin-dependent diabetes mellitus.
Diabetes, 1984; 33 (Suppl. 1):161A.
- Katial A, K Roshto, T Higgs, F Taub.
Peroxidase labeled nucleic acid probes. Poster presented to the
American Society of Biological Chemists, Washington, DC, 1986.
- Taub F, H Rutherford.
Processing images of radioautographs to analyze nucleic acid
hybridizations: a computerized method to study multiple gene
expression. Poster presented to the American Society of
Biolgoical Chemists, Washington, DC 1986.
- Katial A, K Roshto, E Cantin, F Taub.
Detection of herpes virus using peroxidase labeled nucleic acid
probes. Poster presented at the 1st Annual ASM Conference on
Biotechnology, Washington, DC, 1986.
- Roshto K, T Higgs, A Shaikh, J Saba, F Taub.
Background reduction in filter hybridizations. The use of direct
nucleic acid horseradish peroxidase conjugates. Poster presented
to the American Society of Biological Chemists, 1987.
- Grillo S, M Mosher, P Charles, S Henry, F
Taub. DNA/DNA in situ hybridization with enzyme linked
probes. Poster presented to the American Society of
Biological Chemists, 1987.
- Grillo SL, CM Bruns, ME Mosher, FE Taub.
The use of direct DNA-peroxidase conjugates for rapid,
non-radioactive detection of HPV sequences by in situ
hybridization. Poster presented at the 6th International
Papillomavirus Workshop, Washington, DC, 1987. Published in
Abstracts of Papers Presented at the Sixth International
Papillomavirus Workshop, p.105.
- Mosher ME, SL Grillo, N Moore, A Maters, R Ambinder, FE
Taub. Rapid detection of herpesviruses by in
situ hybridization with enzyme-linked probes. Poster presented at
the 12th International Herpesvirus Workshop, Philadelphia, PA,
1987.
- Mosher ME, SL Grillo, N Moore, A Maters, M Forman, R
Ambinder, FE Taub. Rapid detection of
virus-infected cells by in situ hybridization using DNA
probes directly linked to active enzymes. Poster presented
at Gene Probe Technology II: 1987 American Association for
Clinical Chemistry San Diego Conference.
- Mosher M, A Maters, D Jones, M Forman, S Grillo, F
Taub. Rapid detection of cytomegalovirus-infected cells by in
situ hybridization with enzyme-linked DNA probes. Abstracts of
the Annual Meeting of the American Society for Microbiology, 1988,
p.320.
- Bruns CM, C Cardozo, CR Ceccarelli, L Corey, JM Douglas,
SL Grillo, A Langenberg, J Saba, FE Taub. Rapid in
situ hybridization to HPV DNA sequences in cervical smears using
direct enzyme-labeled DNA probes. Poster presented at the 7th
International Papillomavirus Workshop, Sophia Antipolis, France,
1988. Published in Seventh International Papillomavirus Workshop,
p.30.
- Taub, F. In situ
hybridization in surgical pathology. Talk given at George
Washington University, Washington, D.C. on May 7, 1988, as part of
the series, "Advances in Surgical Pathology."
- Higgs T, N Moore, G Gamerman, C Bruns, D Badawi, F
Taub. Highly sensitive, rapid, and specific detection of HPV
types 6/11 and 16/18 in formalin-fixed paraffin-embedded sections
using directly conjugated HRP-labeled DNA probes. Poster
presented at the 8th International Papillomavirus Workshop, Taos,
NM, 1989. Published in Journal of Cellular Biochemistry,
Suppl.13C, 1989, p.187.
- Bruns CM, CR Ceccarelli, J Summerville, T Higgs, FE
Taub. Type-specific HPV detection in Pap smears by in situ
hybridization with enzyme-DNA conjugates. Poster presented at the
8th International Papillomavirus Workshop, Taos, NM, 1989.
Published in Journal of Cellular Biochemistry, Suppl.13C, 1989,
p.182.
- McClintock JT, A Friedman-Kien, F Taub.
Direct detection of Epstein-Barr virus in tongue tissue smears
from individuals with suspected hairy leukoplakia. Poster
presented to the American Society for Microbiology, New Orleans,
LA, 1989. Published in Abstracts of the 89th Annual Meeting of the
American Society for Microbiology 1989, p.373.
- Wacker WK, JT McClintock, S Strohofer, S Kahn, RP
Baughman, FE Taub. Direct detection of
cytomegalovirus in bronchoalveolar lavages using HRP-labeled DNA
probes and in situ hybridization. Poster presented to
the American Society for Microbiology, New Orleans, LA, 1989.
Published in Abstracts of the 89th Annual Meeting of the American
Society for Microbiology 1989, p.373.
- Badawi D, M Garcia, T Higgs, C King, S Yang, F
Taub. Direct-labeled DNA probes for rapid viral
diagnosis. Poster presented to the Society for Pediatric
Pathology, Aspen, CO, 1989.
- King PC, WK Wacker, RP Robinson, J Colandrea, R Robinson,
FE Taub. Direct detection of CMV in
bronchoalveolar lavage specimens using in situ
hybridization. Poster presented to the Pulmonary Pathology
conference sponsored by the Washington Hospital Center,
Washington, DC, 1989.
- King C, W Wacker, R Baughman, J Colandrea, R Robinson, B
Weinstein, F Taub. CMV detection
in cytologic and histologic specimens, using direct-labeled DNA
probes and in situ hybridization. Poster presented at The
International Academy of Pathology, Boston, MA, 1990. Published in
Modern Pathology 3:52A, 1990.
- King C, W Wacker, R Baughman, J Colandrea, R Robinson, B
Weinstein, F Taub. CMV detection
in cytologic and histologic specimens, using direct-labeled DNA
probes and in situ hybridization. Poster presented at The
International Academy of Pathology, Boston, MA, 1990. Published in
Modern Pathology 3:52A, 1990.
- Taub F, C King, T Higgs. Viral
identification in situ with direct-labeled DNA probes.
Poster presented at the UCLA symposium "Animal Models of Human
Viral Diseases: Relevance to Developmental Therapeutics,"
Keystone, CO, 1990.
- Taub F, S Thaker, H Salim, M Wesoloski, D
Badawi. "Single copy detection" of HPV16 in SiHa cells with direct
HRP-DNA probes. Poster presented at Papillomavirus Workshop 1990,
Heidelberg, Germany, 1990.
- Taub F, JS Park, D Badawi, K Shah.
DNA-HRP probes reveal different morphological patterns of HPV
distribution in benign and malignant neoplastic lesions. Poster
presented at Papillomavirus Workshop 1990, Heidelberg, Germany,
1990.
- Miller W, Caplan S, Shustik C, McQuillan A, Sicilia F,
Batist G, Mayerson S, Taub F. Toxicity and
Biological Effects of Beta-alethine - Report of the First Phase
I/II Study. Poster presented at VII International Multiple
Myeloma Workshop 1999, Stockholm, Sweden 1999.
Publications
concerning Beta-alethine:
- Taub, F. Beta-alethine (Beta LT): A Low
Molecular Weight Cytokine Inducer with Anti-Cancer Properties and
Low Toxicity in Mice and Man? Review of Data to Date. Poster
presented at Cancer Immunosurveillance 1999 - Cancer
Research Institute, New York, New York 1999.
- Taub F, Mayerson S, McQuillan A, Caplan
S, Shustik C, Miller W. Phase I/II Evaluation of Beta LT as an
antilymphoma agent and enhancer of DTH in lymphoma patients.
Poster presented at The International Conference on Molecular
Targets and Cancer Therapeutics, Washington, D.C. 1999.
- Miller WH, Caplan S, Shustik C, McQuillan A, Sicilia F,
Mayerson S, Taub F. Beta-alethine
Immunomodulation in Follicular B Cell Lymphoma and Multiple
Myeloma: Initial Phase I/II Results. Submitted. Blood Supplement
(Part II), November 15, 1999.
- W.H. Miller, Jr., S. Caplan, C., Shustik, A. McQuillan, F.
Sicilia, S. Mayerson and F. Taub. Beta-alethine:
TNF alpha, Antitumor Effects and Delayed Type Hypersensitivity in
Follicular B-Cell Lymphoma. Oral presentation at the ISH 2000
(28th International Congress) Toronto, Ontario, August 2000.
- F. Taub. Review of Beta LT
immunomodulation in lab studies and patients with follicular B
cell lymphoma: Initial phase I/II results. Presented at the
Comprehensive Cancer Care 2000, Arlington, VA, June 2000.
- F. Taub, K. Manos, S. Mayerson. A review
of animal models and human clinical trial data supportive of
beta-alethine (BT) immune therapy for minimal residual disease
(MRD). Presented at the 15th Annual Scientific Meeting of the
Society for Biological Therapy, Seattle, WA October 2000.
- W.H. Miller, Jr., S. Caplan, C., Shustik, A. McQuillan, F.
Sicilia, S. Mayerson and F. Taub.
T cells exhibit increased TNF alpha and delayed type
hypersensitivity responses are restored in patients with B cell
malignancies following administration of beta-alethine. Presented
at the American Association for Cancer Research, 11th
NCI-EORTC-AACR Symposium Amsterdam, The Netherlands, November
2000.
- C.H. Pontzer and F. Taub. Reducing
toxicity of recombinant biomolecules through engineering.
Presented at the Cambridge Healthtech Institute Recombinant
Therapeutics: Antibodies and Biomolecules Conference, Baltimore,
MD, June 2001.
Patents:
- Taub F. Assay for Nucleic Acid Sequences,
Particularly Genetic Lesions, Using Interactive Labels.
- Taub F. Bifunctional DNA-Protein
Conjugating Agent.
- Taub F, Higgs TW, Roshto K.
Macromolecular Conjugate.
- Higgs TW, Taub F. A Highly Sensitive
Method for Detecting Peroxidase.
- Taub FE, Lazar J. Macromolecular
Conjugate Made by (confidential).
Scientific
Presentations, Conferences and Public Relations in 2003 & 2004
for Taurox
- Fatigue
Reduction and Quality of Life Enhancement Following Therapy
with Taurox. (Presentation at Exeter University (UK) December
2006) Floyd E. Taub, M.D., Char Tara Albert, Lesley Crowder, Suzin
Mayerson Wright, Ph.D.
- 11th Annual Meeting of the Society for
Orthomolecular Health-Medicine (OHM) in San Francisco,
California, February 24-27, 2005, Fatigue Reduction Due to
Changing Cytokine Patterns. Immunostimulation by COBAT
(Taurox SB) in Patients with Lyme Disease
- KFNX News Talk Radio, August 8th, 2004,
8:00 a.m. PST
Floyd Taub, M.D. was interviewed by Dr.
Warren Levin, Host of the show, "Third Opinion"
- Familynet Television Interview June 17
and 25, 2004
BioInnovations produces a daily television
show for the Familynet cable network, which broadcasts to over
30-million viewers mainly in the Midwest and South, hosted by Dr.
Richard Becker and his wife Cindy. Allergy Research Group, one of
Dovetail's distributors introduced the Beckers to Dr. Floyd Taub,
Dovetail Technology's Chairman and Chief Medical Officer.
Dr. Taub participated in two 30-minute television shows on June
17, 2004 discussing Taurox research. One aired live on Familynet
Television that day, the second program aired on June 25, 2004.
Familynet is a television service dedicated to health and family
matters and provides holistic medical information that is
generally not available to its audience other than through Dr.
Becker.
- Health Sciences Institute (HIS)
Newsletter, May 2004 Issue
HIS published an article
entitled 'What the Goldilocks effect' can do for fatigue and your
immune system , covering Taurox research and products.
Sample
Presentations by Dr. Floyd Taub:
- Society For Orthomolecular
Health-Medicine, 11th Annual Scientific Meeting, About Lyme:
Testing, Diagnosis, Therapeutic Protocols, February 27, 2005, San
Francisco, California, �Fatigue Reduction Through Changing
Cytokine Patterns�.
- American Academy of Environmental
Medicine 39th Annual Meeting, October 28 - 31, 2004, Hilton Head
Island, South Carolina. �Taurox SB� - the First Available
NanoDrug��
- Fourth World Conference on Nutritional
Medicine in San Francisco, California American Association for
Chronic Fatigue Syndrome, Sixth Biennial. May 28, 2004,
�Taurox and NanoDrugs��
- International College of Integrative
Medicine International Congress, September 10�September 14, 2003,
St. Louis, MO. �Beta Alanine
Containing NanoDrugs in the Treatment of Fatigue in Patients
with Chronic Fatigue Syndrome Cancer, and HCV.�
- First International Conference on Whole
Person Healing, March 28�March 30, 2003, Washington, DC.
�Immunomodulator Taurox SB� Reduces Fatigue in Patients with
Cancer, HCV and Chronic Fatigue Syndrome.�
- International Research and Clinical
Conference, January 31�February 2, 2003, Chantilly, VA. �Therapy
with the Cytokine Modulator Is Associated with Decreased Fatigue
in Patients with Chronic Fatigue.�
Listing of
Scientific Research concerning Taurox
- Taurox SB� -- Molecular Activity, Safety,
and Efficacy, Taub, F.E.
- Data on Fatigue, Allergies and Hepatitis
from Structured Case Histories and Clinical Outcome Trials of
Taurox�
- Taurox� Clinical Trials Protocol
- In Vitro Cell Culture In Media Containing
Beta-Alanyl-Taurine or Carbobenzoxy Beta-Alanyl-Taurine, Knight,
G. D., Scanlen, T. J., University of New Mexico, Issued U.S.
Patent Number 6,323,025 B1, November 27, 2001
- In Vitro Cell Culture In Media Containing
Beta-Alanyl-Taurine or Carbobenzoxy Beta-Alanyl-Taurine, Knight,
G. D., Scanlen, T. J., University of New Mexico, Issued U.S.
Patent Number 6,096,536, August 1, 2000
- The Anticancer Properties of Taurox SB
may be Mediated by an Immunostimulatory Mechanism, Dunn, T.M.,
Wormsley, S., Taub, F.E., and Pontzer, C.H. Abstract presented at
the American Society for Pharmacology and Experimental
Therapeutics.
- The Immunostimulatory Effects of Taurox
SB�, Dunn, T. M., Taub, F. E., Pontzer, C H., Department of Cell
Biology and Molecular Genetics, University of Maryland, Submitted
for publication 2001
- Thesis on the Immunostimulatory Effects
of Taurox SB�, Dunn, T. M., Department of Pharmacology and
Experimental Therapeutics, University of Maryland at Baltimore
School of Medicine, 2000
- Therapeutic Use of Vitalethine Modulators
in Neoplasis, Knight, G. D., Scanlen, T. J., University of New
Mexico, Issued U.S. Patent Number 5,578,313, November 26, 1996
- Therapeutic Use of Vitalethine Modulators
in Neoplasia, Knight, G. D., Scanlen, T. J., University of New
Mexico, Issued U.S. Patent Number 5,370,868, December 4, 1994
- Vitalethine Modulates Erythropoisis and
Neoplasia, Knight, G. D., Laubscher, K. H., Fore, M. L.,
Clark� Scanlen, T. J., Cancer Research, 1994; 54(21): 5623-35
Taurox Monograph and
Toxicology Documents Available
- Addendum to Toxicology Monograph on
Taurox SB, Rice, S. A., April 1, 2002 (Confidential)
- Taurox SB Review Of Dr. Susan Rice's
Toxicology Monograph And Response To 4 November 2001 MRC Meeting
Report Questions, Hood, R. D., March 29, 2002 (Confidential).
- Comparison of Toxicity Risks of Five
Common Homeopathic Drugs and Taurox SB, Foxman, E. L., October
23, 2001 (Confidential)
- Proving Report Taurox SB, Riley, D.,
Integrative Medicine Institute, 2001 (Confidential)
- Toxicology Monograph on Taurox SB, Rice,
S. A., September 13, 2001 (Confidential)
- Taurox Monograph Submissions, May 2001
and September 2001 (Confidential)
Floyd Taub M.D.
Floyd.Taub.MD@gmail.com
303 249-9174
Fax: (206) 600-6413
Fitzsimmons Bioscience Center
Colorado Science and
Technology Park
12635 E. Montview Blvd. Suite 100G
Aurora, CO 80045.